share_log

Piper Sandler Maintains Neutral on Globus Medical, Raises Price Target to $60

Piper Sandler Maintains Neutral on Globus Medical, Raises Price Target to $60

派珀·桑德勒对Globus Medical保持中立,将目标股价上调至60美元
Benzinga ·  05/08 12:03

Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Neutral and raises the price target from $55 to $60.

派杰投资分析师Matt O'Brien中立维持Globus Medical (纽交所:GMED) 的目标价从$55上调至$60。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发